Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05465200

Lower Silesia Cardiogenic Shock Initiative

Coordinated Treatment of Cardiogenic Shock Patients in Lower Silesia, Poland

Status
Recruiting
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Wroclaw Medical University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

LSCSI is a Hub\&Spoke project with the main aim to improve the outcome of patients with cardiogenic shock in Lower Silesia region, Poland. It consists of one "hub" which is Wroclaw University Hospital and eleven "spokes" which are eleven cardiology departments situated in Lower Silesian Voivodeship. The consortium have unified protocol defining which cardiogenic shock patient and when should be transferred to the "hub" for enhanced treatment options including durable mechanical circulatory support or heart transplant. The "hub" have 7/24 Shock Team on-site supplied with a protocol how to proceed with "spoke" transferred patients including decision making on which mechanical circulatory support implant with subsequent de-escalation or escalation pathway.

Detailed description

LSCSI is a Hub\&Spoke project with the main aim to improve the outcome of patients with cardiogenic shock in Lower Silesia region, Poland. It consists of one "hub" which is Wroclaw University Hospital and eleven "spokes" which are eleven cardiology departments situated in Lower Silesian Voivodeship. The consortium have unified protocol defining which cardiogenic shock patient and when should be transferred to the "hub" for enhanced treatment options including durable mechanical circulatory support or heart transplant. Shared cardiogenic shock definition: 1. Systolic blood pressure \< 90 mmHg for \> 30 minutes or need for vasopressors use to maintain systolic blood pressure \> 90 mmHg 2. Lactate level \> 2.0 mmol/L 3. Pulmonary capillary wedge pressure or left ventricle end diastolic pressure \> 15 mmHg (excluding pulmonary embolism) 4. Cardiac Index ≤ 2.2 l/min/m2 5. Diuresis \< 30 ml/h 6. Clinical signs of peripheral hypoperfusion Data required by "hub" from "spoke" 1. Echocardiography with data on left and right ventricle function 2. Current aortic and mixed venous blood gases 3. Pulmonary artery catheter measurements including calculation of cardiac power, pulmonary artery pulsatile index, cardiac output, cardiac index, pulmonary artery wedge pressure, pulmonary vascular resistance, systemic vascular resistance (excluding pulmonary embolism) 4. Peripheral blood tests including liver and kidney function, morphology, troponin, natriuretic peptides 5. Currently used and possible for use vascular accesses 6. For pulmonary embolism: computed tomography of pulmonary arteries Upon telephone contact "hub" shock team decides on patients transfer or further treatment in "spoke" facility. When decision on transfer is taken shock team members gather at emergency room when patient arrives and decides on treatment options according to shock team protocol. As a "hub" Wroclaw University Hospital provides mechanical circulatory support (Intra-aortic balloon pump, Impella CP (Cardiac Power), Impella 5.0, Impella RP (Right Pump), ECMO (ExtraCorporeal Membrane Oxygenation), Levitronix, HeartMate3) together with heart transplant program as a regional reference center for advanced heart failure patients. Additionally for acute pulmonary embolism complicated by shock "hub" provides peripheral or local thrombolysis and in case of contraindication for thrombolysis - transcatheter thrombectomy or surgical embolectomy.

Conditions

Interventions

TypeNameDescription
PROCEDUREStructured treatment of cardiogenic shock patientsCreation of hub\&spoke structure which covers all Lower Silesian Voivodeship (Poland) for treatment of cardiogenic shock patients. Based on shared protocol patients are reported to "hub" by "spoke" and decision is made as for patient transfer or further treatment in the "spoke" facility. If decision on transfer is made, patient is further treated according to "hub" on site shock team protocol

Timeline

Start date
2022-01-01
Primary completion
2027-01-01
Completion
2028-01-01
First posted
2022-07-19
Last updated
2025-04-02

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT05465200. Inclusion in this directory is not an endorsement.